The Global Fund Advocates Network Asia-Pacific (GFAN AP) is an advocacy platform of HIV, tuberculosis and malaria community and civil society advocates in the Asia-Pacific region. We support advocacy for a fully resourced Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), increased & sustainable domestic resource mobilisation for health, and equitable, people-centred, human rights-based, & gender transformative inclusion of HIV, TB and malaria responses within Universal Health Coverage (UHC).
What’s New
World Hepatitis Day 2026
This statement is jointly released by GFAN AP, the Seven Alliance (a consortium of Asia-Pacific networks: APCOM, APN+, APNSW, APTN, ICWAP, NAPUD, Youth LEAD) and World Hepatitis Alliance calling on government, donors and relevant stakeholders to come together with communities and civil society collectively and meaningfully to recognise that eliminating viral hepatitis is inseparable from ending HIV and TB, achieving Universal Health Coverage (UHC) and protecting the health and rights of people across Asia and Pacific.
Korean Advocates for Global Health and K-Bio Deliver Malaria Elimination Proposals to MOFA
South Korea hosted the inaugural Korea-Africa Foreign Ministers’ Meeting in Seoul from May 31 to June 2, 2026. Following the historic 2024 Korea-Africa Summit, this meeting gathered delegates from 50 African nations and four regional organisations to pave the way for the next full summit, which is targeted for 2029. This engagement reflects growing momentum to translate Korea’s global health leadership into concrete, country level impact across Africa. Read more on the statement developed and submitted ahead of the Korea-Africa Foreign Ministers’ Meeting to the Ministry of Foreign Affairs by KAGH and K-Bio.
#MoreNowThanEver: Communities Lead the Call to Sustain Pakistan’s HIV, TB and Malaria Response
APLHIV Pakistan and GFAN AP brought community advocates, parliamentarians, diplomats and health partners together in Islamabad to call for sustained support for the Global Fund and predictable financing for HIV, tuberculosis and malaria responses.










